Circulation Research, Vol 68, 1621-1627, Copyright © 1991 by American Heart Association

ARTICLES

Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles

RL Haberl, PJ Decker and KM Einhaupl
Department of Neurology, University of Munich, FRG.

This study demonstrates that the hexapeptide angiotensin II-(3-8) and L- arginine, generated through enzymatic degradation of angiotensin, mediate endothelium-dependent dilation in rabbit brain arterioles. Topical application of angiotensin II (10(-5) M) on the brain surface of anesthetized rabbits caused 21.6 +/- 4.5% (mean +/- SEM) cerebral arteriolar dilation. The cyclooxygenase inhibitor indomethacin did not change this dilation. The natural degradation product of angiotensin II in the brain, angiotensin III, also induced vasodilation at concentrations of 10(-7) to 10(-5) M. The dilation to angiotensin II and angiotensin III was eliminated in the presence of 10(-5) M methylene blue, a known inhibitor of endothelium-dependent vasodilation. Amastatin, an aminopeptidase inhibitor and blocker of enzymatic angiotensin degradation, also inhibited the response to angiotensin II and angiotensin III. The angiotensin fragment angiotensin II-(3-8), which lacks the amino-terminal L-arginine residue of angiotensin III, did not elicit an arteriolar response. When angiotensin II-(3-8) was topically applied subsequent to L-arginine, a 21.2 +/- 2.9% vasodilation was observed. L-Arginine itself induced only moderate vasodilation with a maximum of 4.0 +/- 0.9% at 10(-5) M L- arginine. The dilating response to angiotensin II-(3-8) after L- arginine was inhibited by methylene blue. It was not affected by amastatin. It is concluded that degradation products of angiotensin, rather than angiotensin II itself, induce endothelium-dependent dilation in rabbit brain arterioles without involvement of cyclooxygenase products.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				T. M. De Silva, B. R.S. Broughton, G. R. Drummond, C. G. Sobey, and A. A. Miller Gender Influences Cerebral Vascular Responses to Angiotensin II Through Nox2-Derived Reactive Oxygen Species Stroke, April 1, 2009; 40(4): 1091 - 1097. [Abstract] [Full Text] [PDF]

				X. C. Li, D. J. Campbell, M. Ohishi, S. Yuan, and J. L. Zhuo AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1024 - F1033. [Abstract] [Full Text] [PDF]

				J.-M. Vincent, Y. W. Kwan, S. Lung Chan, C. Perrin-Sarrado, J. Atkinson, and J.-M. Chillon Constrictor and Dilator Effects of Angiotensin II on Cerebral Arterioles Stroke, December 1, 2005; 36(12): 2691 - 2695. [Abstract] [Full Text] [PDF]

				S. P. Didion and F. M. Faraci Angiotensin II Produces Superoxide-Mediated Impairment of Endothelial Function in Cerebral Arterioles Stroke, August 1, 2003; 34(8): 2038 - 2042. [Abstract] [Full Text] [PDF]

				J. Lee, T. Mustafa, S. G. McDowall, F. A. O. Mendelsohn, M. Brennan, R. A. Lew, A. L. Albiston, and S. Y. Chai Structure-Activity Study of LVV-Hemorphin-7: Angiotensin AT4 Receptor Ligand and Inhibitor of Insulin-Regulated Aminopeptidase J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 205 - 211. [Abstract] [Full Text]

				T. Mustafa, Joo Hyung Lee, Siew Yeen Chai, A. L Albiston, S. G McDowall, and F. A. Mendelsohn Bioactive angiotensin peptides: focus on angiotensin IV Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 205 - 210. [PDF]

				J.-K. Chen, J. Zimpelmann, R. C. Harris, and K. D. Burns Angiotensin IV induces tyrosine phosphorylation of focal adhesion kinase and paxillin in proximal tubule cells Am J Physiol Renal Physiol, June 1, 2001; 280(6): F980 - F988. [Abstract] [Full Text] [PDF]

				C. Dimitropoulou, R. E. White, L. Fuchs, H. Zhang, J. D. Catravas, and G. O. Carrier Angiotensin II Relaxes Microvessels Via the AT2 Receptor and Ca2+-Activated K+ (BKCa) Channels Hypertension, February 1, 2001; 37(2): 301 - 307. [Abstract] [Full Text] [PDF]

				S. Chen, J. M. Patel, and E. R. Block Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium release Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L849 - L856. [Abstract] [Full Text] [PDF]

				M. de Gasparo, K. J. Catt, T. Inagami, J. W. Wright, and Th. Unger International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev., September 1, 2000; 52(3): 415 - 472. [Abstract] [Full Text] [PDF]

				B. P. Rowe and B. Dixon Angiotensin III Depressor Action in the Conscious Rabbit Is Blocked by Losartan but not PD 123319 Hypertension, January 1, 2000; 35(1): 130 - 134. [Abstract] [Full Text] [PDF]

				R. K. Handa, J. W. Harding, and S. M. Simasko Characterization and Function of the Bovine Kidney Epithelial Angiotensin Receptor Subtype 4 Using Angiotensin IV and Divalinal Angiotensin IV as Receptor Ligands J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1242 - 1249. [Abstract] [Full Text]

				B. K. Slinker, Y. Wu, A. J. Brennan, K. B. Campbell, and J. W. Harding Angiotensin IV has mixed effects on left ventricle systolic function and speeds relaxation Cardiovasc Res, June 1, 1999; 42(3): 660 - 669. [Abstract] [Full Text] [PDF]

				J. W. Wright, L. Stubley, E. S. Pederson, E. A. Kramar, J. M. Hanesworth, and J. W. Harding Contributions of the Brain Angiotensin IV-AT4 Receptor Subtype System to Spatial Learning J. Neurosci., May 15, 1999; 19(10): 3952 - 3961. [Abstract] [Full Text] [PDF]

				N. HILL-KAPTURCZAK, M. H. KAPTURCZAK, E. R. BLOCK, J. M. PATEL, T. MALINSKI, K. M. MADSEN, and C. C. TISHER Angiotensin II-Stimulated Nitric Oxide Release from Porcine Pulmonary Endothelium Is Mediated by Angiotensin IV J. Am. Soc. Nephrol., March 1, 1999; 10(3): 481 - 491. [Abstract] [Full Text]

				J. M. Patel, J. R. Martens, Y. D. Li, C. H. Gelband, M. K. Raizada, and E. R. Block Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation Am J Physiol Lung Cell Mol Physiol, December 1, 1998; 275(6): L1061 - L1068. [Abstract] [Full Text] [PDF]

				K. Zhang and K. P. Patel Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R728 - R734. [Abstract] [Full Text] [PDF]

				J.-L. Liu, H. Murakami, and I. H. Zucker Angiotensin II–Nitric Oxide Interaction on Sympathetic Outflow in Conscious Rabbits Circ. Res., March 9, 1998; 82(4): 496 - 502. [Abstract] [Full Text] [PDF]

				R. K. Handa, L. T. Krebs, J. W. Harding, and S. E. Handa Angiotensin IV AT4-receptor system in the rat kidney Am J Physiol Renal Physiol, February 1, 1998; 274(2): F290 - F299. [Abstract] [Full Text] [PDF]

				F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF]

				A.-P. Zou, F. Wu, and A. W. Cowley Jr Protective Effect of Angiotensin II-Induced Increase in Nitric Oxide in the Renal Medullary Circulation Hypertension, January 1, 1998; 31(1): 271 - 276. [Abstract] [Full Text] [PDF]

				K. F. Hilgers, E. Bingener, C. Stumpf, D. N. Muller, R. E. Schmieder, and R. Veelken Angiotensinases Restrict Locally Generated Angiotensin II to the Blood Vessel Wall Hypertension, January 1, 1998; 31(1): 368 - 372. [Abstract] [Full Text] [PDF]

				C. M. Boulanger, L. Caputo, and B. I. Levy Endothelial AT1-Mediated Release of Nitric Oxide Decreases Angiotensin II Contractions in Rat Carotid Artery Hypertension, November 1, 1995; 26(5): 752 - 757. [Abstract] [Full Text]

				M. A. Maktabi, M. M. Todd, and G. Stachovic Angiotensin II Contributes to Cerebral Vasodilatation During Hypoxia in the Rabbit Stroke, October 1, 1995; 26(10): 1871 - 1876. [Abstract] [Full Text]

				N. Seyedi, X. Xu, A. Nasjletti, and T. H. Hintze Coronary Kinin Generation Mediates Nitric Oxide Release After Angiotensin Receptor Stimulation Hypertension, July 1, 1995; 26(1): 164 - 170. [Abstract] [Full Text]